Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study

• Published in: Scientific reports Vol. 12; no. 1; p. 1269
• Main Authors: Kuo, Ko-Lin, Liu, Jia-Sin, Lin, Ming-Huang, Hsu, Chih-Cheng, Tarng, Der-Cherng
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 24.01.2022; Nature Publishing Group UK; Nature Portfolio
• Subjects: Adult; Aged; Anemia; Anemia - blood; Anemia - etiology; Anemia - mortality; Cardiovascular diseases; Dialysis; Erythropoiesis; Erythropoietin; Female; Ferritin; Ferritins - blood; Hemoglobin; Humans; Iron; Kidney diseases; Kidney Failure, Chronic - blood; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - mortality; Kidney Failure, Chronic - therapy; Male; Middle Aged; Mortality; Peritoneal Dialysis; Peritoneum; Registries; Retrospective Studies; Supplements; Taiwan - epidemiology; Transferrins; Young Adult; Taiwan

In 1996, the National Health Insurance Administration of Taiwan applied a restrictive reimbursement criteria for erythropoiesis-stimulating agents (ESAs) use in patients with chronic kidney disease. The maximal ESAs dosage allowed by insurance is capped at 20,000 U of epoetin per month. Nephrologist...